Eganelisib
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Eganelisib, covering 2025-10-22 to 2026-03-03. Get the full timeline:
Most recent: Clinical Trial Update: Assessing PI3K Gamma Inhibition With Azacitidine, Venetoclax and Eganelisib in Patients With Acute Myeloid Leukemia [Phase 1]